Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TELA Bio (TELA)
NASDAQ:TELA
TELA Bio (TELA) Stock Price & Analysis
97 Followers
TELA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.23 - $11.26
Previous Close$5.8
Volume115.26K
Average Volume (3M)162.27K
Market Cap
$143.00M
Enterprise Value$136.79M
Total Cash (Recent Filing)$46.73M
Total Debt (Recent Filing)$40.52M
Price to Earnings (P/E)-3.5
Beta0.50
Next Earnings
Aug 07, 2024EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.67
Shares Outstanding24,655,371
10 Day Avg. Volume260,520
30 Day Avg. Volume162,268
Standard Deviation0.16
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)8.49
Price to Sales (P/S)8.41
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.34
Enterprise Value/Gross Profit3.38
Enterprise Value/Ebitda-4.36
Forecast
1Y Price Target
$13.25Price Target Upside127.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
TELA Bio News
PremiumCompany Announcements
TELA Bio Reveals Strategic Direction in Updated Investor Deck
Ownership Overview
57.37% Insiders
11.08% Mutual Funds
16.93% Other Institutional Investors
14.62% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TELA FAQ
What was TELA Bio’s price range in the past 12 months?
TELA Bio lowest stock price was $4.23 and its highest was $11.26 in the past 12 months.
What is TELA Bio’s market cap?
Currently, no data Available
When is TELA Bio’s upcoming earnings report date?
TELA Bio’s upcoming earnings report date is Aug 07, 2024 which is in 84 days.
How were TELA Bio’s earnings last quarter?
TELA Bio released its earnings results on May 09, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.489 by $0.259.
Is TELA Bio overvalued?
According to Wall Street analysts TELA Bio’s price is currently Undervalued.
Does TELA Bio pay dividends?
TELA Bio does not currently pay dividends.
What is TELA Bio’s EPS estimate?
TELA Bio’s EPS estimate is -$0.46.
How many shares outstanding does TELA Bio have?
TELA Bio has 24,655,370 shares outstanding.
What happened to TELA Bio’s price movement after its last earnings report?
TELA Bio reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.489. Following the earnings report the stock price went up 16.802%.
Which hedge fund is a major shareholder of TELA Bio?
Currently, no hedge funds are holding shares in TELA
---
TELA Bio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.25 (127.66% Upside)
$13.25 (127.66% Upside)
Blogger Sentiment
Bullish
TELA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.52%
12-Months-Change
Fundamentals
Return on Equity
-459.89%
Trailing 12-Months
Asset Growth
22.20%
Trailing 12-Months
Company Description
TELA Bio
TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
---
TELA Earnings Call
Q1 2024
0:00 / 0:00
---
TELA Stock 12 Month Forecast
Average Price Target
$13.25
▲(127.66% Upside)
Technical Analysis
AMN Healthcare Services
―
Becton Dickinson
―
Edwards Lifesciences
―
Merit Medical Systems
―
Best Analysts Covering TELA
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
-8.45%
reiterated a buy rating 6 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of -8.45% per trade.
---